Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Corcept Therapeutics Incorporated (CORT) Institutional Ownership & Insider Trading

417 institutions reported holding Corcept Therapeutics Incorporated shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 123 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CORTCorcept Therapeutics IncorporatedFollow CORT — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
9.3B
P/E TTM
204.4
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

417 institutions held 76.0% of the shares. Across filers that reported both quarters, shares held changed +2.9%.

Increased+136New+113Decreased-100Closed-42

Largest moves, shares (millions)

AQR Capital Management+2.2MFuller & Thaler Asset…+0.7MJacobs Levy Equity…+0.7MSio Capital Management-0.7MJane Street Group-0.4MRenaissance Technologies-0.4M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-2.1Sep 24-4.5Dec 24-0.9Mar 25-4.1Jun 25-0.1Sep 25-2.6Dec 25+3.5Mar 26+2.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2641782+2.9%13611310042
Mar 2634679+5.3%1055311389
Dec 2537976-3.4%1083813781
Sep 2541978-0.1%1254713642
Jun 2541579-5.3%1346114154
Mar 2540278-1.2%1148812835
Dec 2435984-5.1%1055610422
Sep 2431487-2.9%94479425

Corcept Therapeutics Incorporated — questions

Who owns Corcept Therapeutics Incorporated stock?
417 institutions reported Corcept Therapeutics Incorporated shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (11.5%), INGALLS & SNYDER LLC (7.3%), RENAISSANCE TECHNOLOGIES LLC (4.9%).
Are Corcept Therapeutics Incorporated insiders buying or selling?
123 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Corcept Therapeutics Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.